SBRT to adrenal metastases provides high local control with minimal toxicity

by Kristin Plichta, MD, PhD, Nathan Camden, BS, Muhammed Furqan, MD, Taher Abu Hejleh, MBBS, Gerald H. Clamon, MD, Jun Zhang, MD, PhD, Ryan T. Flynn, PhD, Sudershan K. Bhatia, MD, PhD, Mark C. Smith, MD, John M. Buatti, MD, Bryan G. Allen, MD, PhD
Published 2017-10-01